UPDATE 1-Myovant Sciences' uterine fibroids combo therapy meets main goal in study [Reuters]
Myovant Sciences Ltd. Common Shares (MYOV)
Last myovant sciences ltd. common shares earnings: 2/10 08:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.myovant.com
Company Research
Source: Reuters
UPDATE 1-Myovant Sciences' uterine fibroids combo therapy meets main goal in study (Adds details on study, disease, share movement) May 14 (Reuters) - Myovant Sciences Ltd said on Tuesday its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids. The company said 73.4% of women receiving the once-daily treatment showed a greater reduction in menstrual blood loss compared with 18.9% of women receiving placebo. The treatment, consisting of Myovant’s Relugolix and hormone therapies estradiol and norethindrone acetate, also helped maintain bone mineral density at levels comparable to placebo over 24 weeks and was generally well tolerated. Uterine fibroids are non-cancerous tumors that develop in or on the muscular walls of the uterus and are among the most common reproductive tract tumors, affecting about 5 million women in the United States. There are currently limited treatment options for uterine fibroids, which cause heavy men
Show less
Read more
Impact Snapshot
Event Time:
MYOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYOV alerts
High impacting Myovant Sciences Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics